Company profile

Sight

Pioneering a New Generation of Immune Signatures, by Decoding Live Immune Cells In Action

Industry
Biotechnology Research
Employees
64
Headquarters
Tel Aviv, Israel
Founded
2011
LinkedIn followers
16,279
Office locations
2

Sight company summary

Sight is a company in the Biotechnology Research industry, headquartered in Tel Aviv, Israel, founded in 2011. On LinkedIn the company has around 64 employees and 16,279 followers. The company lists 2 office locations.

What technology does Sight use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Sight

Combining cutting-edge AI with exclusive, proprietary data generated by its patented multidisciplinary fluorescent microscopy platform, Sight® is quantifying immune activation by capturing and decoding live immune cells in action — pioneering a new generation of immune signatures at scale. Sight has built a new category in diagnostics: a powerful immune intelligence platform built entirely on groundbreaking technology developed in-house by our team. Protected by more than 100 global patents, our platform stands on a technology foundation that has been proven, regulated, manufactured, and deployed at scale. Our unique technology measures the live functional state of immune cells directly from blood in real-time. By using AI-driven digital biomarkers to map cell populations according to their physical behavior, our algorithms decode distinctive, information-rich patterns of immune response. This represents a fundamentally different approach to diagnostics: not an incremental biomarker assay, but a new way to read the immune system directly from live blood. Engineered as a versatile infrastructure, our platform acts as an engine for immune insights across multiple products and markets using the same hardware and test kits. We targeted the greatest unmet clinical needs of immune diagnostics — spanning infectious diseases, oncology and immunotherapy treatment monitoring, and autoimmune diseases.

Where is Sight located?

Sight lists 2 office locations.

Tel Aviv, Israel, ILHQ
23 Menahem Begin street
Brooklyn, New York, US
68 34th St

Compare companies similar to Sight

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Sight
sightdx.com
Biotechnology Research642011Tel Aviv, Israel
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Sight

What does Sight do?

Combining cutting-edge AI with exclusive, proprietary data generated by its patented multidisciplinary fluorescent microscopy platform, Sight® is quantifying immune activation by capturing and decoding live immune cells in action — pioneering a new generation of immune signatures at scale. Sight has built a new category in diagnostics: a powerful immune intelligence platform built entirely on groundbreaking technology developed in-house by our team. Protected by more than 100 global patents, our platform stands on a technology foundation that has been proven, regulated, manufactured, and deployed at scale. Our unique technology measures the live functional state of immune cells directly from blood in real-time. By using AI-driven digital biomarkers to map cell populations according to their physical behavior, our algorithms decode distinctive, information-rich patterns of immune response. This represents a fundamentally different approach to diagnostics: not an incremental biomarker assay, but a new way to read the immune system directly from live blood. Engineered as a versatile infrastructure, our platform acts as an engine for immune insights across multiple products and markets using the same hardware and test kits. We targeted the greatest unmet clinical needs of immune diagnostics — spanning infectious diseases, oncology and immunotherapy treatment monitoring, and autoimmune diseases.

How many employees does Sight have?

Sight has around 64 employees on LinkedIn.

Where is Sight headquartered?

Sight is headquartered in Tel Aviv, Israel.

Where does Sight have offices?

Sight lists 2 office locations, including Tel Aviv, Israel, IL; Brooklyn, New York, US.

When was Sight founded?

Sight was founded in 2011.

Build a lead list from companies like Sight

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.